AUDENTES THERAPEUTICS INC's ticker is BOLD and the CUSIP is 05070R104. A total of 89 filers reported holding AUDENTES THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $16,810,000 | +118.7% | 280,904 | +2.7% | 0.01% | +80.0% |
| Q3 2019 | $7,687,000 | -9.8% | 273,630 | +21.5% | 0.01% | 0.0% |
| Q2 2019 | $8,524,000 | +7.1% | 225,122 | +10.4% | 0.01% | 0.0% |
| Q1 2019 | $7,959,000 | +90.7% | 203,964 | +4.2% | 0.01% | +66.7% |
| Q4 2018 | $4,173,000 | -38.3% | 195,693 | +14.6% | 0.00% | -40.0% |
| Q3 2018 | $6,760,000 | +161.4% | 170,733 | +152.3% | 0.01% | +150.0% |
| Q2 2018 | $2,586,000 | +88.6% | 67,660 | +48.4% | 0.00% | +100.0% |
| Q1 2018 | $1,371,000 | +26.7% | 45,597 | +31.8% | 0.00% | 0.0% |
| Q4 2017 | $1,082,000 | +50.7% | 34,597 | +35.1% | 0.00% | 0.0% |
| Q3 2017 | $718,000 | +46.5% | 25,600 | 0.0% | 0.00% | – |
| Q2 2017 | $490,000 | +167.8% | 25,600 | +139.3% | 0.00% | – |
| Q1 2017 | $183,000 | -6.6% | 10,700 | 0.0% | 0.00% | – |
| Q4 2016 | $196,000 | – | 10,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SYQUANT CAPITAL SAS | 767,502 | $45,927,000 | 23.65% |
| Chicago Capital Management, LLC | 250,401 | $14,984,000 | 12.57% |
| Foresite Capital Management III, LLC | 233,067 | $13,947,000 | 7.82% |
| Partner Investment Management, L.P. | 17,795 | $1,065,000 | 7.65% |
| RAMIUS ADVISORS LLC | 220,784 | $13,212,000 | 5.68% |
| Beryl Capital Management LLC | 550,426 | $32,937,000 | 5.31% |
| GARDNER LEWIS ASSET MANAGEMENT L P | 647,460 | $38,744,000 | 5.28% |
| FNY Investment Advisers, LLC | 278,861 | $16,687,000 | 5.17% |
| WHITE SQUARE CAPITAL LLP | 112,500 | $6,732,000 | 4.87% |
| Casdin Capital, LLC | 860,000 | $51,462,000 | 4.73% |